| REPORT ATTRIBUTE |
DETAILS |
| Historical Period |
2019-2022 |
| Base Year |
2023 |
| Forecast Period |
2024-2032 |
| United Kingdom Periodontal Disease Market Size 2023 |
USD 162.43 Million |
| United Kingdom Periodontal Disease Market, CAGR |
5.71% |
| United Kingdom Periodontal Disease Market Size 2032 |
USD 272.77 Million |
Market Overview
The United Kingdom Periodontal Disease Market is expected to grow from USD 162.43 million in 2023 to USD 272.77 million by 2032, at a compound annual growth rate (CAGR) of 5.71%.
The United Kingdom periodontal disease market is driven by an increasing awareness of oral health and the rising prevalence of periodontal diseases. Factors such as the aging population, growing incidence of risk factors like smoking and diabetes, and the availability of advanced diagnostic tools and treatments contribute to market growth. Additionally, improvements in dental care technology, including laser therapies and minimally invasive surgical techniques, are enhancing treatment outcomes, further propelling market demand. The trend towards preventive care and greater adoption of dental health insurance is also boosting the market. Moreover, the increasing focus on research and development of novel therapeutic agents and the expansion of dental care services are expected to drive the market’s growth in the coming years. These factors, combined with rising healthcare expenditure and patient awareness, support the expansion of the periodontal disease market in the United Kingdom.
The United Kingdom periodontal disease market is influenced by geographical variations in access to care and awareness levels. Major urban centers like London, Manchester, and Birmingham have a higher concentration of dental professionals and specialized clinics, driving demand for both preventive and advanced periodontal treatments. In contrast, rural areas may face challenges related to limited access to specialized care and lower awareness of periodontal disease. Key players in the UK market include leading dental care providers such as Bausch Health Companies Inc., Henry Schein, Dentsply Sirona Inc., and Biolase, Inc., which offer a range of diagnostic tools, non-surgical treatments, and advanced technologies like laser therapy. These companies, along with regional clinics such as Al-FaPerio Clinic, are critical in shaping the landscape of periodontal care in the UK. The increasing prevalence of periodontal disease, especially among older populations, ensures that these players will continue to play a vital role in improving oral health across the country.
Access crucial information at unmatched prices!
Request your free sample report today & start making informed decisions powered by Credence Research!
Download Free Sample
Market Insights
- The United Kingdom periodontal disease market is valued at USD 162.43 million in 2023 and is projected to reach USD 272.77 million by 2032, growing at a CAGR of 5.71%.
- Increasing awareness of the connection between periodontal disease and systemic health conditions, such as diabetes and cardiovascular disease, is driving market growth.
- The aging population is a key factor, as older individuals are more susceptible to periodontal disease.
- Limited access to dental care, especially in rural areas, poses a challenge to market expansion.
- High treatment costs, particularly for advanced procedures, can limit patient access to necessary care.
- Urban areas like London, Manchester, and Birmingham show stronger market activity due to higher awareness and better access to care.
- Technological advancements in diagnostics and minimally invasive treatments are fostering market growth by improving patient outcomes and satisfaction.
Market Drivers
Aging Population
The aging population is a significant driver of periodontal disease in the United Kingdom. As individuals age, their immune systems may weaken, making them more susceptible to gum infections. For instance, a study projected that the number of older adults with periodontal disease in the UK will increase significantly by 2050. Longer life expectancies also contribute to the prolonged exposure to periodontal disease, with more individuals experiencing its long-term effects. Aging individuals often face challenges in maintaining oral hygiene, which increases the risk of gum disease and complicates treatment, further driving the demand for dental care and periodontal treatments.
Poor Oral Hygiene Practices
Inadequate oral hygiene is a key factor in the development of periodontal disease. Many individuals neglect proper brushing and flossing, leading to plaque buildup and gum inflammation. For instance, a survey found that a significant portion of adults in the UK do not brush their teeth twice a day, which is the recommended practice. Without regular dental check-ups, which are crucial for early detection and treatment, periodontal disease can progress undetected. These poor hygiene practices significantly contribute to the rising incidence of periodontal disease, highlighting the need for greater awareness and access to preventive dental care.
Systemic Health Conditions
Certain systemic health conditions increase the risk of developing severe periodontal disease. For instance, individuals with diabetes are more prone to gum infections due to impaired immune function, while those with cardiovascular disease face a higher risk of complications related to periodontal disease. Studies have also linked periodontal disease to an increased risk of heart disease and stroke. The growing prevalence of these conditions is driving the demand for periodontal care as part of comprehensive health management.
Smoking and Lifestyle Factors
Smoking is a significant contributor to periodontal disease, as it impairs the body’s ability to heal and exacerbates chronic inflammation. For instance, smoking is a well-established risk factor for periodontitis, and smokers are more likely to develop severe gum disease. Additionally, lifestyle factors such as chronic stress and poor diet, particularly high sugar and processed food intake, further contribute to periodontal disease. These factors weaken the immune system, promote plaque buildup, and increase gum inflammation, creating a need for targeted prevention and treatment strategies.
Market Trends
Rising Prevalence and Growing Awareness
The rising prevalence of periodontal disease in the United Kingdom is driven by several factors. The aging population is contributing to a higher incidence, as older individuals are more susceptible to gum infections and the long-term effects of periodontal disease. Poor oral hygiene practices, including inconsistent brushing and flossing, continue to be a significant cause of gum inflammation and plaque buildup. Additionally, the increasing prevalence of systemic health conditions like diabetes and cardiovascular disease, which are linked to periodontal disease, further fuels the demand for periodontal treatments. Public health campaigns by government and dental organizations are playing a crucial role in raising awareness about the importance of oral health and the risks of periodontal disease. For instance, the National Smile Month campaign educates millions of people about the benefits of a healthy smile. These efforts aim to educate the public on preventive measures and encourage early intervention, thus helping to curb the rising cases of periodontal disease in the country.
Advancements in Treatment and Preventive Care
Technological advancements are transforming the management of periodontal disease. The integration of advanced diagnostic tools, such as intraoral cameras and digital X-rays, enables early detection of gum disease, allowing for prompt intervention and better treatment outcomes. Furthermore, there is a growing demand for minimally invasive treatments, with laser therapy gaining popularity as a less painful and more effective option. Regenerative dentistry techniques, such as platelet-rich plasma (PRP) therapy and bone grafting, are also emerging as key treatment modalities that promote tissue regeneration and enhance recovery. Alongside these advancements, there is an increasing focus on preventive care. Regular dental check-ups and professional cleanings are becoming essential in preventing periodontal disease, with oral hygiene products such as electric toothbrushes and specialized mouthwashes seeing growing demand. The integration of digital health is another emerging trend, with telehealth consultations and mobile apps allowing patients to access dental care remotely, track oral health habits, and receive personalized advice. The economic impact of periodontal disease is significant, not only due to direct costs like dental treatments and medications but also because it affects individuals’ productivity and quality of life, further highlighting the importance of early detection and effective management.
Market Challenges Analysis
Awareness Gaps and Access Challenges
One of the key challenges in the United Kingdom periodontal disease market is the limited awareness among individuals regarding the severity of the condition and its potential impact on overall health. Many people remain unaware of the connection between gum disease and systemic health issues such as cardiovascular disease and diabetes. For instance, a survey found that nearly half of adults in the UK were unaware of the link between oral health and systemic diseases. This lack of awareness, combined with the stigma associated with poor oral health, often prevents individuals from seeking timely treatment. Additionally, inequitable access to dental care exacerbates the issue, particularly in marginalized communities and rural areas where access to quality care and specialized periodontal treatments is limited. Socioeconomic disparities further compound these challenges, as individuals in lower-income brackets may not have the financial means to afford necessary treatments or preventive care, leading to delayed diagnoses and worsening oral health outcomes.
Treatment Barriers and Need for Research
Another significant challenge is the high cost of advanced periodontal treatments, such as laser therapy and regenerative procedures like platelet-rich plasma (PRP) therapy, which can be prohibitively expensive for many patients. Even with the availability of dental insurance, coverage for periodontal treatments is often limited, leaving patients to bear substantial out-of-pocket costs. Additionally, adherence to complex treatment plans can be difficult, as many patients struggle to maintain regular dental visits or follow through with home care regimens. Poor patient compliance often results in suboptimal treatment outcomes and increases the risk of disease recurrence. Moreover, modifying lifestyle factors, such as smoking and poor diet, presents a challenge, as these habits are deeply ingrained and require ongoing support to change. Despite the advancements in treatment, there remains a need for further research and innovation in periodontal care. Investment in developing more effective, minimally invasive therapies is crucial to address the evolving needs of the market and improve patient outcomes in the long term.
Market Opportunities
The United Kingdom periodontal disease market presents significant opportunities driven by increasing awareness and the growing demand for advanced treatments. With rising awareness of the link between periodontal disease and systemic health conditions, such as diabetes and cardiovascular disease, there is an expanding need for early detection and preventive care. Public health campaigns and educational initiatives are opening avenues for oral health professionals to educate the public on the importance of periodontal health. As the demand for early intervention grows, there is a notable opportunity for providers to offer diagnostic tools, such as intraoral cameras and digital X-rays, that facilitate early diagnosis and effective treatment planning. Additionally, the increasing prevalence of the aging population in the UK further amplifies the need for specialized periodontal care, creating opportunities for dental practices to cater to the unique needs of older patients.
Technological advancements also present considerable growth prospects in the periodontal disease market. The rising adoption of minimally invasive treatments, such as laser therapy and regenerative dentistry techniques, is a key opportunity for the industry. These treatments not only provide improved patient outcomes but also enhance the overall patient experience by reducing recovery times and minimizing discomfort. Furthermore, as more patients embrace preventive care, the market for advanced oral hygiene products, such as electric toothbrushes and specialized mouthwashes, continues to expand. The growing integration of digital health solutions, including telehealth consultations and mobile apps for tracking oral health, offers an innovative opportunity for dental professionals to connect with patients remotely and improve compliance with treatment plans. These trends highlight a significant opportunity for growth and innovation within the periodontal disease market.
Market Segmentation Analysis:
By Type:
The United Kingdom periodontal disease market is segmented by type into several categories, including Gingivitis, Chronic Periodontal Disease, Aggressive Periodontal Disease, Type 4, and Type 5. Gingivitis, the earliest stage of periodontal disease, remains the most common form, driven by factors like poor oral hygiene and smoking. It can be treated effectively with non-surgical methods and regular dental cleanings. Chronic Periodontal Disease is more severe and requires comprehensive treatment strategies, often involving surgical interventions. Aggressive Periodontal Disease, although less common, affects younger individuals and leads to rapid loss of tooth-supporting structures. The Type 4 and Type 5 categories likely represent more advanced or complex forms of periodontal disease, requiring specialized care. These segments collectively contribute to the market’s growth as they represent various stages of periodontal disease, each necessitating different therapeutic approaches and driving the demand for both preventive and advanced treatment options.
By Application:
The application segment of the UK periodontal disease market includes Non-surgical Treatment, Surgical Treatment, and other specialized applications. Non-surgical treatments, such as scaling and root planing, are widely used for treating early-stage periodontal disease, particularly Gingivitis, and are cost-effective and minimally invasive. Surgical treatments, including gum grafts and periodontal flap surgery, are required for more severe cases like Chronic Periodontal Disease and Aggressive Periodontal Disease, where non-surgical methods may be insufficient. As the market evolves, there is increasing interest in advanced treatments and technologies, which have created new application areas that include regenerative procedures and laser treatments. These developments are aimed at improving treatment outcomes, minimizing patient recovery time, and enhancing patient satisfaction. The demand for these treatments is expected to grow as patients seek less invasive and more effective solutions, particularly with rising awareness of periodontal disease and its systemic health implications.
Segments:
Based on Type:
- Gingivitis
- Chronic Periodontal Disease
- Aggressive Periodontal Disease
- Type 4
- Type 5
Based on Application:
- Non-surgical Treatment
- Surgical Treatment
- Application 3
- Application 4
- Application 5
Based on Therapeutics:
- Systematic Antibiotics
- Local Antibiotics
- Therapeutics 3
- Therapeutics 4
- Therapeutics 5
Based on End Users:
- Hospitals
- Dental Clinic
- Dental Academics
- Research Institutes and Others
- End Users 5
Based on Distribution Channel:
- Distribution Channel 1
- Distribution Channel 2
- Distribution Channel 3
- Distribution Channel 4
- Distribution Channel 5
Based on the Geography:
- London
- Manchester
- Birmingham
- Scotland
Regional Analysis
London
London holds the largest share of the United Kingdom periodontal disease market, accounting for approximately 35% of the total market revenue. As the capital city, London is home to a significant portion of the country’s population and has a high concentration of healthcare facilities, including specialized dental clinics. For instance, the Adult Dental Health Survey indicates that London has a higher prevalence of dental clinics and professionals compared to other regions in the UK. This concentration of advanced dental care providers, along with a higher level of awareness about oral health, contributes to the market dominance of London. The city also benefits from an affluent population with better access to periodontal treatments, including both preventive and advanced care. Furthermore, with its diverse demographic, including older populations at higher risk for periodontal disease, London is expected to continue driving market growth. For example, the National Health Service (NHS) has implemented several oral health initiatives aimed at improving periodontal health awareness. The rise in public health campaigns, educational initiatives, and technological advancements in diagnostic tools further support the increasing demand for periodontal care in this region.
Birmingham
Birmingham follows London in market share, with a strong presence in the periodontal disease market, accounting for around 25% of the total market. As the second-largest city in the UK, Birmingham benefits from a well-established healthcare infrastructure and a diverse population that includes a significant number of older adults. The city’s health-conscious population, combined with rising awareness of the link between periodontal disease and systemic health conditions like diabetes and cardiovascular disease, contributes to the growing demand for periodontal treatments. Additionally, Birmingham’s proximity to leading dental research institutions and ongoing advancements in dental care technologies further drive the market growth.
Key Player Analysis
- Bausch Health Companies Inc.
- Colgate-Palmolive Company
- Mylan N.V.
- Lyne Laboratories
- WOCKHARDT
- Xttrium Laboratories
- Sunstar Suisse S.A.
- 3M
- Izun Pharmaceuticals
- Tolmar Pharmaceuticals, Inc.
- Company 11
- Company 12
- Company 13
- Company 14
Competitive Analysis
The United Kingdom periodontal disease market is highly competitive, with several leading players offering a range of diagnostic tools, treatment solutions, and advanced technologies. Key players in the market include Bausch Health Companies Inc., Henry Schein, Geistlich Pharma AG, Lyne Laboratories, ENVISTA HOLDINGS CORPORATION, DENTSPLY SIRONA Inc., 3M, Amyndas Pharmaceuticals, Biolase, Inc., Al-FaPerio Clinic. Companies in this market are focusing on innovation, especially in the areas of diagnostics and treatment options, to meet the growing demand for effective periodontal care. Non-surgical treatments, such as laser therapy and scaling, are gaining popularity due to their minimal recovery times and less invasive nature. The shift toward minimally invasive treatments is being driven by advancements in technology, with newer equipment and procedures improving patient outcomes and satisfaction. In addition to technological advancements, companies are expanding their portfolios to include regenerative therapies, such as platelet-rich plasma (PRP) treatments and bone grafting, which are essential for patients with advanced periodontal disease. Furthermore, competition is increasing as dental practices and specialized clinics seek to differentiate themselves by offering personalized services and high-quality care. Strategic partnerships, acquisitions, and collaborations are key tactics for market players aiming to enhance their capabilities, expand their market share, and address evolving patient needs. This dynamic environment fosters a high level of competition, as companies strive to remain at the forefront of the periodontal care sector.
Recent Developments
- In September 2023, Bausch Health Companies Inc. and its oral health care division, OraPharma announced plans to team up with the League of United Latin American Citizens (LULAC), the biggest Hispanic group in the U.S. Their goal is to spread awareness about gum disease among Hispanic communities. This collaboration aims to help Hispanics better understand how to detect and treat gum disease.
- In June 2023, Eli Lilly and Company finalized an agreement to acquire DICE Therapeutics, Inc., a renowned biopharmaceutical firm recognized for its groundbreaking DELSCAPE technology platform. This platform is instrumental in creating novel oral therapeutic candidates, such as oral IL-17 inhibitors, which are presently in clinical development. These treatments are designed to target chronic immune-related diseases.
- In March 2023, Haleon initiated the #BetterOralCareNation campaign in Malaysia to enhance oral health practices across the country. The campaign seeks to raise awareness about the importance of oral hygiene and promote better oral care habits among Malaysians.
- In April 2023, Novo Nordisk collaborated with Aspect Biosystems, a company involved in bioprinting biomaterials, for the development of bioprinted tissue therapeutics for obesity and diabetes.
- In March 2022, Biocomposites signed an agreement with Zimmer Biomet to distribute the new genex Bone Graft Substitute. Genex Bone Graft Substitute is a biphasic composite of exceptional purity specifically formulated to balance osteoconductive scaffold strength and persistence in the body to enable the optimal remodeling of bone architecture.
- In February 2022, Envista Holding Corporation formed a strategic partnership with the Spanish Dental Service Organization- Vitaldent Group. This helps the company to become the preferred supplier of dental implants.
Market Concentration & Characteristics
The market concentration of the United Kingdom periodontal disease sector is relatively moderate, with a mix of both established players and specialized clinics offering a range of diagnostic tools and treatment options. While larger companies dominate the market with comprehensive portfolios, there is significant competition from smaller, niche players focusing on specialized periodontal care, such as regenerative therapies and minimally invasive treatments. This diversity ensures a dynamic market with a variety of offerings catering to different patient needs. Major players invest heavily in research and development, driving technological advancements in diagnostics and treatment methodologies, particularly in the areas of laser therapy and digital imaging. The market is characterized by a shift toward patient-centered care, with increased emphasis on personalized treatments and advanced technologies that offer faster recovery and minimal discomfort. Additionally, there is growing demand for preventive care, with more people seeking regular check-ups and early interventions to prevent the progression of periodontal disease. Geographic disparities exist, with urban areas benefiting from better access to specialized care compared to rural regions. Overall, the United Kingdom periodontal disease market is evolving with increasing patient awareness, technological innovations, and an expanding range of treatment options, while maintaining a competitive balance between large companies and smaller specialized practices.
Shape Your Report to Specific Countries or Regions & Enjoy 30% Off!
Report Coverage
The research report offers an in-depth analysis based on Type, Application, Therapeutics, End Users, Distribution Channel and Geography. It details leading market players, providing an overview of their business, product offerings, investments, revenue streams, and key applications. Additionally, the report includes insights into the competitive environment, SWOT analysis, current market trends, as well as the primary drivers and constraints. Furthermore, it discusses various factors that have driven market expansion in recent years. The report also explores market dynamics, regulatory scenarios, and technological advancements that are shaping the industry. It assesses the impact of external factors and global economic changes on market growth. Lastly, it provides strategic recommendations for new entrants and established companies to navigate the complexities of the market.
Future Outlook
- The United Kingdom periodontal disease market is expected to grow steadily, driven by an aging population and increased awareness of oral health’s link to overall well-being.
- Technological advancements, particularly in diagnostic tools and minimally invasive treatments, will continue to shape the market.
- The demand for non-surgical treatments, such as laser therapy, is anticipated to rise as patients seek less invasive and more convenient options.
- Regenerative treatments, including platelet-rich plasma (PRP) therapy, will see increased adoption as they offer better outcomes for patients with advanced periodontal disease.
- Public health initiatives will play a key role in raising awareness about the importance of early diagnosis and treatment.
- The shift toward preventive care, with an emphasis on regular check-ups and oral hygiene, will drive market growth in the coming years.
- The integration of digital health solutions, including telehealth consultations and mobile apps, will make dental care more accessible.
- Socioeconomic factors will continue to affect access to periodontal care, with efforts to address health disparities in underserved areas gaining importance.
- The market will see increased competition, with both large players and smaller, specialized practices offering differentiated products and services.
- As research progresses, new treatment options and improved therapeutic outcomes will expand the potential of periodontal disease management.
